- Home
- ARQQ vs LVTX Comparison
ARQQ vs LVTX Comparison
Compare ARQQ & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQQ
- LVTX
- Stock Information
- Founded
- ARQQ 2017
- LVTX 2016
- Country
- ARQQ United Kingdom
- LVTX Netherlands
- Employees
- ARQQ N/A
- LVTX N/A
- Industry
- ARQQ Computer Software: Prepackaged Software
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- ARQQ Technology
- LVTX Health Care
- Exchange
- ARQQ Nasdaq
- LVTX Nasdaq
- Market Cap
- ARQQ 282.1M
- LVTX 25.3M
- IPO Year
- ARQQ N/A
- LVTX 2021
- Fundamental
- Price
- ARQQ $29.29
- LVTX $1.03
- Analyst Decision
- ARQQ Strong Buy
- LVTX Buy
- Analyst Count
- ARQQ 1
- LVTX 3
- Target Price
- ARQQ $27.00
- LVTX $3.33
- AVG Volume (30 Days)
- ARQQ 1.4M
- LVTX 169.6K
- Earning Date
- ARQQ 12-31-2024
- LVTX 12-10-2024
- Dividend Yield
- ARQQ N/A
- LVTX N/A
- EPS Growth
- ARQQ N/A
- LVTX N/A
- EPS
- ARQQ N/A
- LVTX N/A
- Revenue
- ARQQ $293,000.00
- LVTX $7,345,000.00
- Revenue This Year
- ARQQ $3,516.04
- LVTX N/A
- Revenue Next Year
- ARQQ N/A
- LVTX N/A
- P/E Ratio
- ARQQ N/A
- LVTX N/A
- Revenue Growth
- ARQQ N/A
- LVTX N/A
- 52 Week Low
- ARQQ $3.72
- LVTX $0.96
- 52 Week High
- ARQQ $42.90
- LVTX $6.47
- Technical
- Relative Strength Index (RSI)
- ARQQ 56.31
- LVTX 32.44
- Support Level
- ARQQ $22.30
- LVTX $0.96
- Resistance Level
- ARQQ $42.90
- LVTX $1.95
- Average True Range (ATR)
- ARQQ 6.82
- LVTX 0.16
- MACD
- ARQQ 0.02
- LVTX -0.05
- Stochastic Oscillator
- ARQQ 31.69
- LVTX 6.55
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product QuantumCloud. The firm operates in one segment that is, the provision of cybersecurity services via satellite and terrestrial platforms. The company operates and generates its revenue from UK.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.